Foreign establishment registration
Executive Summary
FDA plans to prohibit importation of drugs from foreign manufacturers that are not listed with the agency under its proposed rule for Foreign Establishment Registration and Listing, published May 14. The rule, mandated by the FDA Modernization Act, would require foreign drug establishments to register with FDA, list all of their imported products, and to identify a U.S. agent